Fecal Microbiota Transplant in Pediatric Crohn's Disease (PediCRaFT Trial)
Updated: Jul 5, 2021
McMaster Children’s Hospital is looking for children ages 3 to 17 years old, diagnosed with Crohn’s disease or IBD-U to participate in the first Health Canada approved fecal microbiota transplant (FMT) trial for children suffering from Crohn’s disease across Canada.
The PediCRaFT (Pediatric CRohn’s Disease Fecal Microbiota Transplant) Trial is the first Health Canada approved fecal microbiota transplant (FMT) trial for children with Crohn’s disease across Canada. This trial is being led by the McMaster Pediatric Fecal Microbiota Transplant program, under the supervision of Dr. Nikhil Pai, pediatric gastroenterologist at McMaster Children’s Hospital. The team has extensive experience in pediatric FMT, having recently completed a three-year randomized trial of FMT in children with ulcerative colitis. We collaborate closely with leaders in FMT Research through the McMaster University Division of Adult Gastroenterology, and McMaster University Farncombe Family Digestive Health Research Institute.
To learn more, please contact: Lee Hill (firstname.lastname@example.org)
Additional information available at: